Diabetes Drugs May Lead to Pancreatic Cancer

Diabetes drug users should beware of a potential increased risk of cancer, . According to a new study, those who have prescriptions for the diabetes drugs Januvia or Byetta are at a heightened risk of pancreatic cancer, while Byetta may also boost the risk of thyroid cancer.

Although experts stress that the current research is not enough to form any firm conclusions, the findings do warrant some alarm, as well as further studies.

Risk of pancreatic cancer is also linked to obesity, just as diabetes is. So before giving up the meds, the best initial advice to diabetics looking to avoid pancreatic cancer is to lose some weight.

Unfortunately, this study isn’t the first to link diabetes drugs with cancer. Users of Actos were found to have a significantly greater risk of bladder cancer. On the other hand, untreated diabetes also can leave you vulnerable to cancer. Another study found that men with type 2 diabetes have an increased chance of developing colorectal cancer.

Perhaps the best way to avoid all of these diabetes-related cancer risks is to do your best from developing diabetes in the first place. Consider consuming more dairy products to improve your health and prevent diabetes.


  • My friend was at a major store last week that would not give their Rewards coupon if you used a newspaper coupon for the item. They said it was their policy!!! i told her to check “123 Get Samples” to find samples


    Diabetes has already been reversed for over 20,000 people, it is the drug makers who hid the story.

    The Anti Obesity drug makers and diabetes drug makers take in 10 billion$$$$ every year with no cure but you do not need their drugs.

    There is no need for any “drug” for Type 2 Diabetes. The drugs cause direct heart attacks. Diabetes is being reversed out medications with a specialized diet

    click HERE http://spirithappy.org/wp/new-type-2-diabetes-diet-cure/


  • chromium vitamin for diabetes, the primary clinical strategy to improve metabolic control in patients with Type 2 diabetes consists of lifestyle modification combined with pharmacologic intervention. However, alternative strategies, e.g. nutritional supplementation with over-the-counter agents, are extensively practiced by a large number of patients and are frequently undertaken without first informing the medical provider. http://www.1wallmart.com/product.php?id_product=321 Unfortunately, considerable controversy exists regarding use of dietary supplements in subjects with diabetes because efficacy data for many of the supplements consists of only uncontrolled studies and anecdotal reports. As such, there is a paucity of data in humans in regard to the effect of most commercially available supplements to improve metabolic abnormalities. One supplement that has attracted considerable clinical interest is chromium (Cr). However, routine use of Cr in subjects with diabetes is not currently recommended. In part, the controversy surrounding Cr supplementation stems from the lack of definitive randomized trials, the lack of “gold standard” techniques to assess glucose metabolism in the studies reported, the use of differing doses and formulation , and the study of heterogeneous study populations. As such, conflicting data has been reported that has contributed greatly to the confusion among healthcare providers concerning Cr supplementation. In order to provide a comprehensive clinical evaluation of Cr, we conducted a randomized, double-blinded, placebo-controlled trial in subjects with Type 2 diabetes. Individuals had baseline measures consisting of oral glucose tolerance testing, body fat and adiposity assessed, and then used established techniques to assess insulin sensitivity with hyperinsulinemic-euglycemic clamps. Individuals were evaluated for 6 months at which time repeat testing was done.

  • Most common risk factors of pancreatic cancer are smoking, age (60 to 80), gender (probably found in women), Diets (high level of sugar, red meat, drink), obesity, diabetes, History of family (some genetic problem)…etc

Leave a Reply

Your email address will not be published. Required fields are marked *